Aug 04, 2020 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Eris Lifesciences Q1 FY '21 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Amit Bakshi, Chairman and Managing Director. Thank you, and over to you, sir.
Amit Indubhushan Bakshi - Eris Lifesciences Limited - Chairman & MD
Hi, everybody. Thanks for joining me in the first quarter earnings report of the company. Let me start with the COVID situation. As all of us are aware that COVID created a lot of havoc in the market. So we started the quarter with the month of April, which was quite disrupted. And we had some preponement of chronic medicines in the month of March. And we started April actually on a very sober note. But as we were welling up, we were realizing that 2 things will work for anybody; one is the chronicity of the portfolio, and second is the number of lead brands within the portfolio.
So it's a very big change in the industry actually. For the first time, I think, in the history of the
Q1 2021 Eris Lifesciences Ltd Earnings Call Transcript
Aug 04, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers